Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus

References

• Agnandji ST, Huttner A, Zinser ME, Njuguna P, Dahlke C, Fernandes JF, Yerly S, Dayer J-A, Kraehling V, Kasonta R, et al. 2016. Phase 1 trials of rVSV Ebola vaccine in Africa and Europe. N Engl J Med. 374(17):1647–1660.
   PubMed Web of Science ®Google Scholar
• Akagi K, Miyazaki T, Oshima K, Umemura A, Shimada S, Morita K, Senju H, Tashiro M, Takazono T, Saijo T, et al. 2020. Detection of viral RNA in diverse body fluids in an SFTS patient with encephalopathy, gastrointestinal bleeding and pneumonia: a case report and literature review. BMC Infect Dis. 20(1):281.
   PubMed Web of Science ®Google Scholar
• Arii J, Goto H, Suenaga T, Oyama M, Kozuka-Hata H, Imai T, Minowa A, Akashi H, Arase H, Kawaoka Y, et al. 2010. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature. 467(7317):859–862.
   PubMed Web of Science ®Google Scholar
• Brown KS, Safronetz D, Marzi A, Ebihara H, Feldmann H. 2011. Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus. J Virol. 85(23):12781–12791.
   PubMed Web of Science ®Google Scholar
• Cai L, Zhang H, Gao L-D, Hu S-X, Xie L-Y, Zhan Z-F, He F-L, Zhang F, Deng Z-H, Sun Q-L, et al. 2019. Identification of the first case of SFTSV infection in the Hunan Province of China and epidemiological surveillance in the locality. Ticks Tick Borne Dis. 10(2):454–461.
   PubMed Web of Science ®Google Scholar
• Chaudhary V, Zhang S, Yuen K-S, Li C, Lui P-Y, Fung S-Y, Wang P-H, Chan C-P, Li D, Kok K-H, et al. 2015. Suppression of type I and type III IFN signalling by NSs protein of severe fever with thrombocytopenia syndrome virus through inhibition of STAT1 phosphorylation and n and activation. J Gen Virol. 96(11):3204–3211.
   PubMedGoogle Scholar
• Chen L, Zhou Y, Li H. 2018. LncRNA, miRNA and lncRNA-miRNA interaction in viral infection. Virus Res. 257:25–32.
   PubMed Web of Science ®Google Scholar
• Chen Y, Jia B, Liu Y, Huang R, Chen J, Wu C. 2017. Risk factors associated with fatality of severe fever with thrombocytopenia syndrome: a meta-analysis. Oncotarget. 8(51):89119–89129.
   PubMedGoogle Scholar
• Choi Y, Jiang Z, Shin W-J, Jung JU. 2019. Severe fever with thrombocytopenia syndrome virus NSs interacts with TRIM21 to activate the p62-Keap1-Nrf2 pathway. J Virol. 94(6):e01684–19.
   Web of Science ®Google Scholar
• Choi Y, Park S-J, Sun Y, Yoo J-S, Pudupakam RS, Foo S-S, Shin W-J, Chen SB, Tsichlis PN, Lee W-J, et al. 2019. Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for viral immunopathogenesis. Nat Microbiol. 4(3):429–437.
   PubMed Web of Science ®Google Scholar
• Choy MM, Zhang SL, Costa VV, Tan HC, Horrevorts S, Ooi EE. 2015. Proteasome inhibition suppresses dengue virus egress in antibody dependent infection. PLoS Negl Trop Dis. 9(11):e0004058.
   PubMed Web of Science ®Google Scholar
• Chyuan IT, Tzeng HT, Chen JY. 2019. Signaling pathways of type I and type III interferons and targeted therapies in systemic lupus erythematosus. Cells. 8(9):963.
   PubMed Web of Science ®Google Scholar
• de Boer SM, Kortekaas J, de Haan CA, Rottier PJ, Moormann RJ, Bosch BJ. 2012. Heparan sulfate facilitates Rift Valley fever virus entry into the cell. J Virol. 86(24):13767–13771.
   PubMed Web of Science ®Google Scholar
• DeBuysscher BL, Scott D, Marzi A, Prescott J, Feldmann H. 2014. Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins. Vaccine. 32(22):2637–2644.
   PubMed Web of Science ®Google Scholar
• Ding F, Zhang W, Wang L, Hu W, Soares Magalhaes RJ, Sun H, Zhou H, Sha S, Li S, Liu Q, et al. 2013. Epidemiologic features of severe fever with thrombocytopenia syndrome in China, 2011–2012. Clin Infect Dis. 56(11):1682–1683.
   PubMed Web of Science ®Google Scholar
• Dong F, Li D, Wen D, Li S, Zhao C, Qi Y, Jangra RK, Wu C, Xia D, Zhang X, et al. 2019. Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus. NPJ Vaccines. 4:5.
   PubMed Web of Science ®Google Scholar
• Dowd KA, Ko S-Y, Morabito KM, Yang ES, Pelc RS, DeMaso CR, Castilho LR, Abbink P, Boyd M, Nityanandam R, et al. 2016. Rapid development of a DNA vaccine for Zika virus. Science. 354(6309):237–240.
   PubMed Web of Science ®Google Scholar
• Essandoh K, Li Y, Huo J, Fan GC. 2016. MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response. Shock. 46(2):122–131.
   PubMed Web of Science ®Google Scholar
• Gai Z, Liang M, Zhang Y, Zhang S, Jin C, Wang S-W, Sun L, Zhou N, Zhang Q, Sun Y, et al. 2012. Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact. Clin Infect Dis. 54(2):249–252.
   PubMed Web of Science ®Google Scholar
• Gai Z-T, Zhang Y, Liang M-F, Jin C, Zhang S, Zhu C-B, Li C, Li X-Y, Zhang Q-F, Bian P-F, et al. 2012. Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. J Infect Dis. 206(7):1095–1102.
   PubMed Web of Science ®Google Scholar
• Gong Z, Gu S, Zhang Y, Sun J, Wu X, Ling F, Shi W, Zhang P, Li D, Mao H, et al. 2015. Probable aerosol transmission of severe fever with thrombocytopenia syndrome virus in southeastern China. Clin Microbiol Infect. 21(12):1115–1120.
   PubMed Web of Science ®Google Scholar
• Gordon S. 2003. Alternative activation of macrophages. Nat Rev Immunol. 3(1):23–35.
   PubMed Web of Science ®Google Scholar
• Haze K, Yoshida H, Yanagi H, Yura T, Mori K. 1999. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell. 10(11):3787–3799.
   PubMed Web of Science ®Google Scholar
• Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, et al. 2017. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). The Lancet. 389(10068):505–518.
   PubMed Web of Science ®Google Scholar
• Hoffmann HH, Schneider WM, Rice CM. 2015. Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol. 36(3):124–138.
   PubMed Web of Science ®Google Scholar
• Hofmann H, Li X, Zhang X, Liu W, Kühl A, Kaup F, Soldan SS, González-Scarano F, Weber F, He Y, et al. 2013. Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines. J Virol. 87(8):4384–4394.
   PubMed Web of Science ®Google Scholar
• Huang D, Jiang Y, Liu X, Wang B, Shi J, Su Z, Wang H, Wang T, Tang S, Liu H, et al. 2017. A cluster of symptomatic and asymptomatic infections of severe fever with thrombocytopenia syndrome caused by person-to-person transmission. Am J Trop Med Hyg. 97(2):396–402.
   PubMed Web of Science ®Google Scholar
• Huang X-Y, Du Y-H, Wang H-F, You A-G, Li Y, Su J, Nie Y-F, Ma H-X, Xu B-L. 2019. Prevalence of severe fever with thrombocytopenia syndrome virus in animals in Henan Province. Infect Dis Poverty. 8(1):56.
   PubMed Web of Science ®Google Scholar
• Hubálek Z. 2009. Biogeography of tick-borne Bhanja virus (Bunyaviridae) in Europe. Interdiscip Perspect Infect Dis. 2009:372691.
   PubMedGoogle Scholar
• Huttner A, Combescure C, Grillet S, et al. 2017. A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa. Sci Transl Med. 9(385). DOI:10.1126/scitranslmed.aaj1701.
   PubMed Web of Science ®Google Scholar
• Italiani P, Boraschi D. 2014. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol. 5:514.
   PubMed Web of Science ®Google Scholar
• Jeong EJ, Song JY, Lim CS, Lee I, Park M-S, Choi MJ, Jeon JH, Kang SH, Jung BK, Yoon JG, et al. 2016. Viral shedding from diverse body fluids in a patient with severe fever with thrombocytopenia syndrome. J Clin Virol. 80:33–35.
   PubMed Web of Science ®Google Scholar
• Jheng JR, Ho JY, Horng JT. 2014. ER stress, autophagy, and RNA viruses. Front Microbiol. 5(388). DOI:10.3389/fmicb.2014.00388.
   PubMedGoogle Scholar
• Jiang XL, Zhang S, Jiang M, Bi ZQ, Liang MF, Ding SJ, Wang SW, Liu JY, Zhou SQ, Zhang XM, et al. 2015. A cluster of person-to-person transmission cases caused by SFTS virus in Penglai, China. Clin Microbiol Infect Dis. 21(3):274–279.
   Google Scholar
• Jin C, Liang M, Ning J, Gu W, Jiang H, Wu W, Zhang F, Li C, Zhang Q, Zhu H, et al. 2012. Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model. Proc Natl Acad Sci U S A. 109(25):10053–10058.
   PubMed Web of Science ®Google Scholar
• Kato H, Yamagishi T, Shimada T, Matsui T, Shimojima M, Saijo M, Oishi K. 2016. Epidemiological and clinical features of severe fever with thrombocytopenia syndrome in Japan, 2013–2014. PLoS One. 11(10):e0165207.
   PubMed Web of Science ®Google Scholar
• Keck F, Amaya M, Kehn-Hall K, Roberts B, Bailey C, Narayanan A. 2015. Characterizing the effect of Bortezomib on Rift Valley Fever virus multiplication. Antiviral Res. 120:48–56.
   PubMed Web of Science ®Google Scholar
• Khan KH. 2013. DNA vaccines: roles against diseases. Germs. 3(1):26–35.
   PubMedGoogle Scholar
• Kim J, Bae JM. 2019. Epidemiological and clinical characteristics of confirmed cases of severe fever with thrombocytopenia syndrome in Jeju Province, Korea, 2014–2018. J Prev Med Public Health. 52(3):195–199.
   PubMedGoogle Scholar
• Kim KH, Kim J, Ko M, Chun JY, Kim H, Kim S, Min J-Y, Park WB, Oh M-D, Chung J, et al. 2019. An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus. PLoS Pathog. 15(2):e1007375.
   PubMed Web of Science ®Google Scholar
• Kim YR, Yun Y, Bae SG, Park D, Kim S, Lee JM, Cho N-H, Kim YS, Lee KH. 2018. Severe fever with thrombocytopenia syndrome virus Infection, South Korea, 2010. Emerg Infect Dis. 24(11):2103–2105.
   PubMed Web of Science ®Google Scholar
• Koga S, Takazono T, Ando T, Hayasaka D, Tashiro M, Saijo T, Kurihara S, Sekino M, Yamamoto K, Imamura Y, et al. 2019. Severe fever with thrombocytopenia syndrome Virus RNA in Semen, Japan. Emerg Infect Dis. 25(11):2127–2128.
   PubMed Web of Science ®Google Scholar
• Kurup D, Wirblich C, Feldmann H, Marzi A, Schnell MJ. 2015. Rhabdovirus-based vaccine platforms against henipaviruses. J Virol. 89(1):144–154.
   PubMed Web of Science ®Google Scholar
• Kwak J-E, Kim Y-I, Park S-J, Yu M-A, Kwon H-I, Eo S, Kim T-S, Seok J, Choi W-S, Jeong JH, et al. 2019. Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets. Nat Commun. 10(1):3836.
   PubMedGoogle Scholar
• Li H, Lu Q-B, Xing B, Zhang S-F, Liu K, Du J, Li X-K, Cui N, Yang Z-D, Wang L-Y, et al. 2018. Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011–17: a prospective observational study. Lancet Infect Dis. 18(10):1127–1137.
   PubMed Web of Science ®Google Scholar
• Li H, Zhang L-K, Li S-F, Zhang S-F, Wan W-W, Zhang Y-L, Xin Q-L, Dai K, Hu Y-Y, Wang Z-B, et al. 2019. Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality. Cell Res. 29(9):739–753.
   PubMed Web of Science ®Google Scholar
• Li J, Han Y, Xing Y, Li S, Kong L, Zhang Y, Zhang L, Liu N, Wang Q, Wang S, et al. 2014. Concurrent measurement of dynamic changes in viral load, serum enzymes, T cell subsets, and cytokines in patients with severe fever with thrombocytopenia syndrome. PLoS One. 9(3):e91679
   PubMed Web of Science ®Google Scholar
• Li S, Li H, Zhang Y-L, Xin Q-L, Guan Z-Q, Chen X, Zhang X-A, Li X-K, Xiao G-F, Lozach P-Y, et al. 2020. SFTSV infection induces BAK/BAX-dependent mitochondrial DNA release to trigger NLRP3 inflammasome activation. Cell Rep. 30(13):4370–4385 e7.
   PubMed Web of Science ®Google Scholar
• Li Z, Bao C, Hu J, Liu W, Wang X, Zhang L, Ji Z, Feng Z, Li L, Shen A, et al. 2016. Ecology of the tick-borne phlebovirus causing severe fever with thrombocytopenia syndrome in an endemic area of China. PLoS Negl Trop Dis. 10(4):e0004574.
   PubMed Web of Science ®Google Scholar
• Lin T-L, Ou S-C, Maeda K, Shimoda H, Chan JP-W, Tu W-C, Hsu W-L, Chou C-C. 2020. The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan. Emerg Microbes Infect. 9(1):148–151.
   PubMed Web of Science ®Google Scholar
• Liu J, Thorp SC. 2002. Cell surface heparan sulfate and its roles in assisting viral infections. Med Res Rev. 22(1):1–25.
   PubMed Web of Science ®Google Scholar
• Liu K, Zhou H, Sun RX, et al. 2015. A national assessment of the epidemiology of severe fever with thrombocytopenia syndrome, China. Sci Rep. 5:9679.
   PubMed Web of Science ®Google Scholar
• Liu MM, Lei XY, Yu H, Zhang JZ, Yu XJ. 2017. Correlation of cytokine level with the severity of severe fever with thrombocytopenia syndrome. Virol J. 14(1):6.
   PubMedGoogle Scholar
• Liu Q, He B, Huang S-Y, Wei F, Zhu X-Q. 2014. Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. Lancet Infect Dis. 14(8):763–772.
   PubMed Web of Science ®Google Scholar
• Liu S, Liu H, Zhang K, Li X, Duan Y, Wang Z, Wang T. 2019. Proteasome inhibitor PS-341 effectively blocks infection by the severe fever with thrombocytopenia syndrome virus. Virol Sin. 34(5):572–582.
   PubMed Web of Science ®Google Scholar
• Liu W, Li H, Lu Q-B, Cui N, Yang Z-D, Hu J-G, Fan Y-D, Guo C-T, Li X-K, Wang Y-W, et al. 2016. Candidatus rickettsia tarasevichiae infection in Eastern Central China: a case series. Ann Intern Med. 164(10):641–648.
   PubMed Web of Science ®Google Scholar
• Liu W, Lu Q-B, Cui N, Li H, Wang L-Y, Liu K, Yang Z-D, Wang B-J, Wang H-Y, Zhang Y-Y, et al. 2013. Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome. Clin Infect Dis. 57(9):1292–1299.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li Q, Hu W, Wu J, Wang Y, Mei L, Walker DH, Ren J, Wang Y, Yu X-J. 2012. Person-to-person transmission of severe fever with thrombocytopenia syndrome virus. Vector Borne Zoonotic Dis. 12(2):156–160.
   PubMed Web of Science ®Google Scholar
• Low JG, Sung C, Wijaya L, Wei Y, Rathore APS, Watanabe S, Tan BH, Toh L, Chua LT, Hou Y, et al. 2014. Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet Infect Dis. 14(8):706–715.
   PubMed Web of Science ®Google Scholar
• Lu Q-B, Li H, Zhang P-H, Cui N, Yang Z-D, Fan Y-D, Cui X-M, Hu J-G, Guo C-T, Zhang X-A, et al. 2016. Severe fever with thrombocytopenia syndrome complicated by co-infection with spotted fever group rickettsiae, China. Emerg Infect Dis. 22(11):1957–1960.
   PubMed Web of Science ®Google Scholar
• Lu Q-B, Zhang S-Y, Cui N, Hu J-G, Fan Y-D, Guo C-T, Qin S-L, Yang Z-D, Wang L-Y, Wang H-Y, et al. 2015. Common adverse events associated with ribavirin therapy for severe fever with thrombocytopenia syndrome. Antiviral Res. 119:19–22.
   PubMed Web of Science ®Google Scholar
• Luo L-M, Zhao L, Wen H-L, Zhang Z-T, Liu J-W, Fang L-Z, Xue Z-F, Ma D-Q, Zhang X-S, Ding S-J, et al. 2015. Haemaphysalis longicornis ticks as reservoir and vector of severe fever with thrombocytopenia syndrome virus in China. Emerg Infect Dis. 21(10):1770–1776.
   PubMed Web of Science ®Google Scholar
• Luo SHT, Wang YN, Zhao M, Lu QJ. 2016. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus. Int Immunopharmacol. 40:542–549.
   PubMed Web of Science ®Google Scholar
• Marzi A, Feldmann F, Geisbert TW, Feldmann H, Safronetz D. 2015. Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses. Emerg Infect Dis. 21(2):305–307.
   PubMed Web of Science ®Google Scholar
• Matsuu A, Momoi Y, Nishiguchi A, Noguchi K, Yabuki M, Hamakubo E, Take M, Maeda K. 2019. Natural severe fever with thrombocytopenia syndrome virus infection in domestic cats in Japan. Vet Microbiol. 236:108346
   PubMed Web of Science ®Google Scholar
• Min YQ, Ning YJ, Wang H, Deng F. 2020. A RIG-I-like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination. J Biol Chem. 295(28):9691–9711.
   PubMed Web of Science ®Google Scholar
• Moss RB. 2009. Prospects for control of emerging infectious diseases with plasmid DNA vaccines. J Immune Based Ther Vaccines. 7(1):3.
   PubMedGoogle Scholar
• Muehlenbachs A, Fata CR, Lambert AJ, Paddock CD, Velez JO, Blau DM, Staples JE, Karlekar MB, Bhatnagar J, Nasci RS, et al. 2014. Heartland virus-associated death in tennessee. Clin Infect Dis. 59(6):845–850.
   PubMed Web of Science ®Google Scholar
• Nguyen NM, Tran CNB, Phung LK, Duong KTH, Huynh H. l A, Farrar J, Nguyen QTH, Tran HT, Nguyen CVV, Merson L, et al. 2013. A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis. 207(9):1442–1450.
   PubMed Web of Science ®Google Scholar
• Ning Y-J, Feng K, Min Y-Q, Cao W-C, Wang M, Deng F, Hu Z, Wang H. 2015. Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies. J Virol. 89(8):4227–4236.
   PubMed Web of Science ®Google Scholar
• Ning Y-J, Mo Q, Feng K, Min Y-Q, Li M, Hou D, Peng C, Zheng X, Deng F, Hu Z, et al. 2019. Interferon-γ-directed inhibition of a novel high-pathogenic phlebovirus and viral antagonism of the antiviral signaling by targeting STAT1. Front Immunol. 10:1182.
   PubMed Web of Science ®Google Scholar
• Niu G, Li J, Liang M, et al. 2013. Severe fever with thrombocytopenia syndrome virus among domesticated animals, China. Emerg Infect Dis. 19(5):756–763.
   PubMed Web of Science ®Google Scholar
• Oh WS, Yoo JR, Kwon KT, Kim HI, Lee SJ, Jun JB, Ryu SY, Kim HA, Hur J, Wi YM, et al. 2017. Effect of early plasma exchange on survival in patients with severe fever with thrombocytopenia syndrome: a multicenter study. Yonsei Med J. 58(4):867–871.
   PubMed Web of Science ®Google Scholar
• Okabe Y, Medzhitov R. 2014. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell. 157(4):832–844.
   PubMed Web of Science ®Google Scholar
• Park E-S, Shimojima M, Nagata N, Ami Y, Yoshikawa T, Iwata-Yoshikawa N, Fukushi S, Watanabe S, Kurosu T, Kataoka M, et al. 2019. Severe fever with thrombocytopenia syndrome phlebovirus causes lethal viral hemorrhagic fever in cats. Sci Rep. 9(1):11990.
   PubMedGoogle Scholar
• Park I, Kim HI, Kwon KT. 2017. Two treatment cases of severe fever and thrombocytopenia syndrome with oral ribavirin and plasma exchange. Infect Chemother. 49(1):72–77.
   PubMed Web of Science ®Google Scholar
• Park SW, Ryou J, Choi WY, Han MG, Lee WJ. 2016. Epidemiological and clinical features of severe fever with thrombocytopenia syndrome during an outbreak in South Korea, 2013–2015. Am J Trop Med Hyg. 95(6):1358–1361.
   PubMed Web of Science ®Google Scholar
• Pertmer TM, Oran AE, Moser JM, Madorin CA, Robinson HL. 2000. DNA vaccines for influenza virus: differential effects of maternal antibody on immune responses to hemagglutinin and nucleoprotein. J Virol. 74(17):7787–7793.
   PubMed Web of Science ®Google Scholar
• Qi R, Qin X-r, Wang L, Han H-j, Cui F, Yu H, Liu J-w, Yu X-j. 2019. Severe fever with thrombocytopenia syndrome can masquerade as hemorrhagic fever with renal syndrome. PLoS Negl Trop Dis. 13(3):e0007308.
   PubMed Web of Science ®Google Scholar
• Qu B, Qi X, Wu X, Liang M, Li C, Cardona CJ, Xu W, Tang F, Li Z, Wu B, et al. 2012. Suppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus . J Virol. 86(16):8388–8401.
   PubMed Web of Science ®Google Scholar
• Ra SH, Kim JY, Cha HH, Kwon J-S, Lee H-J, Jeon NY, Kim MJ, Chong YP, Lee S-O, Choi S-H, et al. 2019. Coinfection of severe fever with thrombocytopenia syndrome and scrub typhus in patients with tick-borne illness. Am J Trop Med Hyg. 101(6):1259–1262.
   PubMed Web of Science ®Google Scholar
• Rainey T, Occi JL, Robbins RG, Egizi A. 2018. Discovery of Haemaphysalis longicornis (Ixodida: Ixodidae) parasitizing a sheep in New Jersey, United States. J Med Entomol. 55(3):757–759.
   PubMed Web of Science ®Google Scholar
• Regules JA, Beigel JH, Paolino KM, Voell J, Castellano AR, Hu Z, Muñoz P, Moon JE, Ruck RC, Bennett JW, et al. 2017. A recombinant Vesicular stomatitis virus Ebola vaccine. N Engl J Med. 376(4):330–341.
   PubMed Web of Science ®Google Scholar
• Saijo M. 2018. Pathophysiology of severe fever with thrombocytopenia syndrome and development of specific antiviral therapy. J Infect Chemother. 24(10):773–781.
   PubMed Web of Science ®Google Scholar
• Sang Y, Miller LC, Blecha F. 2015. Macrophage polarization in virus-host interactions. J Clin Cell Immunol. 6(2). DOI:10.4172/2155-9899.1000311.
   PubMedGoogle Scholar
• Santiago FW, Covaleda LM, Sanchez-Aparicio MT, Silvas JA, Diaz-Vizarreta AC, Patel JR, Popov V, Yu X-j, García-Sastre A, Aguilar PV. 2014. Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses. J Virol. 88(8):4572–4585.
   PubMed Web of Science ®Google Scholar
• Sato T, Nishida H, Goto M, Sho Y, Yamate T, Daa T, Yokoyama S, Kurosawa K, Matsunari O, Sakamoto T, et al. 2019. Cutaneous histopathology of the tick-bite region in severe fever with thrombocytopenia syndrome. J Dermatol. 46(5):409–412.
   PubMed Web of Science ®Google Scholar
• Schroder K, Hertzog PJ, Ravasi T, Hume DA. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 75(2):163–189.
   PubMed Web of Science ®Google Scholar
• Shen S, Duan X, Wang B, Zhu L, Zhang Y, Zhang J, Wang J, Luo T, Kou C, Liu D, et al. 2018. A novel tick-borne phlebovirus, closely related to severe fever with thrombocytopenia syndrome virus and Heartland virus, is a potential pathogen. Emerg Microbes Infect. 7(1):95.
   PubMed Web of Science ®Google Scholar
• Shimojima M, Fukushi S, Tani H, Taniguchi S, Fukuma A, Saijo M. 2015. Combination effects of ribavirin and interferons on severe fever with thrombocytopenia syndrome virus infection. Virol J. 12:181.
   PubMed Web of Science ®Google Scholar
• Song P, Zheng N, Liu Y, Tian C, Wu X, Ma X, Chen D, Zou X, Wang G, Wang H, et al. 2018. Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection. Nat Commun. 9(1):3328.
   PubMed Web of Science ®Google Scholar
• Sood R, Porter AC, Ma K, Quilliam LA, Wek RC. 2000. Pancreatic eukaryotic initiation factor-2alpha kinase (PEK) homologues in humans, Drosophila melanogaster and Caenorhabditis elegans that mediate translational control in response to endoplasmic reticulum stress. Biochem J. 346 Pt 2(Pt 2):281–293.
   PubMedGoogle Scholar
• Spengler JR, Bente DA, Bray M, Burt F, Hewson R, Korukluoglu G, Mirazimi A, Weber F, Papa A. 2018. Second international conference on crimean-congo hemorrhagic fever. Antiviral Res. 150:137–147.
   PubMed Web of Science ®Google Scholar
• Sun J, Lu L, Wu H, Yang J, Ren J, Liu Q. 2017. The changing epidemiological characteristics of severe fever with thrombocytopenia syndrome in China, 2011–2016. Sci Rep. 7(1):9236
   PubMedGoogle Scholar
• Sun Y, Jin C, Zhan F, Wang X, Liang M, Zhang Q, Ding S, Guan X, Huo X, Li C, et al. 2012. Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome. J Infect Dis. 206(7):1085–1094.
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu M-M, Luo L-M, Zhao L, Wen H-L, Zhang Z-T, Liu J-W, Xue Z-F, Ma D-Q, Ding S-J, et al. 2017. Seroprevalence of severe fever with thrombocytopenia syndrome virus in Hedgehog from China. Vector Borne Zoonotic Dis. 17(5):347–350.
   PubMed Web of Science ®Google Scholar
• Sun Y, Qi Y, Liu C, Gao W, Chen P, Fu L, Peng B, Wang H, Jing Z, Zhong G, et al. 2014. Nonmuscle myosin heavy chain IIA is a critical factor contributing to the efficiency of early infection of severe fever with thrombocytopenia syndrome virus. J Virol. 88(1):237–248.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Sato Y, Sano K, Arashiro T, Katano H, Nakajima N, Shimojima M, Kataoka M, Takahashi K, Wada Y, et al. 2020. Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections. J Clin Invest. 130(2):799–812.
   PubMed Web of Science ®Google Scholar
• Swei A, Russell BJ, Naccache SN, Kabre B, Veeraraghavan N, Pilgard MA, Johnson BJB, Chiu CY. 2013. The genome sequence of Lone Star virus, a highly divergent bunyavirus found in the Amblyomma americanum tick. PLoS One. 8(4):e62083.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Maeda K, Suzuki T, Ishido A, Shigeoka T, Tominaga T, Kamei T, Honda M, Ninomiya D, Sakai T, et al. 2014. The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan. J Infect Dis. 209(6):816–827.
   PubMed Web of Science ®Google Scholar
• Tang X, Wu W, Wang H, Du Y, Liu L, Kang K, Huang X, Ma H, Mu F, Zhang S, et al. 2013. Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood. J Infect Dis. 207(5):736–739.
   PubMed Web of Science ®Google Scholar
• Tani H, Fukuma A, Fukushi S, Taniguchi S, Yoshikawa T, Iwata-Yoshikawa N, Sato Y, Suzuki T, Nagata N, Hasegawa H, et al. 2016. Efficacy of T-705 (Favipiravir) in the treatment of infections with lethal severe fever with thrombocytopenia syndrome virus. mSphere. 1(1):e00061–15.
   PubMed Web of Science ®Google Scholar
• Tani H, Shimojima M, Fukushi S, Yoshikawa T, Fukuma A, Taniguchi S, Morikawa S, Saijo M. 2016. Characterization of glycoprotein-mediated entry of severe fever with thrombocytopenia syndrome virus. J Virol. 90(11):5292–5301.
   PubMed Web of Science ®Google Scholar
• Tebas P, Roberts CC, Muthumani K, Reuschel EL, Kudchodkar SB, Zaidi FI, White S, Khan AS, Racine T, Choi H, et al. 2017. Safety and immunogenicity of an anti-Zika Virus DNA vaccine - preliminary report. N Engl J Med. DOI:10.1056/NEJMoa1708120.
   Web of Science ®Google Scholar
• Thi Hai Yen N, Kim C, Jeong S, Jeon K, Choi H, Ro H-J, Kim H-I, Kim Y, Kang J-G, Park D, et al. 2019. Severe fever with thrombocytopenia syndrome virus infection or mixed infection with scrub typhus in South Korea in 2000–2003. Am J Trop Med Hyg. 101(5):1096–1099.
   PubMed Web of Science ®Google Scholar
• Tian H, Yu P, Chowell G, Li S, Wei J, Tian H, Lv W, Han Z, Yang J, Huang S, et al. 2017. Severe Fever with thrombocytopenia syndrome virus in humans, domesticated animals, ticks, and mosquitoes, Shaanxi Province, China. Am J Trop Med Hyg. 96(6):1346–1349.
   PubMed Web of Science ®Google Scholar
• Tirasophon W, Welihinda AA, Kaufman RJ. 1998. A stress response pathway from the endoplasmic reticulum to the nucleus requires a novel bifunctional protein kinase/endoribonuclease (Ire1p) in mammalian cells. Genes Dev. 12(12):1812–1824.
   PubMed Web of Science ®Google Scholar
• Tran XC, Yun Y, Van An L, Kim S-H, Thao NTP, Man PKC, Yoo JR, Heo ST, Cho N-H, Lee KH. 2019. Endemic severe fever with thrombocytopenia syndrome, Vietnam. Emerg Infect Dis. 25(5):1029–1031.
   PubMed Web of Science ®Google Scholar
• Tricou V, Minh NN, Van TP, Lee SJ, Farrar J, Wills B, Tran HT, Simmons CP. 2010. A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Negl Trop Dis. 4(8):e785.
   PubMed Web of Science ®Google Scholar
• Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. 2009. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol. 10(11):778–790.
   PubMed Web of Science ®Google Scholar
• Walldorf JA, Cloessner EA, Hyde TB, MacNeil A, Taskforce C. 2019. Considerations for use of Ebola vaccine during an emergency response. Vaccine. 37(48):7190–7200.
   PubMed Web of Science ®Google Scholar
• Wang G-S, Wang J-B, Tian F-L, Zhang H-J, Yin F-F, Xu C, Xu D, Huang Y-T, Yu X-J. 2017. Severe fever with thrombocytopenia syndrome virus infection in minks in China. Vector Borne Zoonotic Dis. 17(8):596–598.
   PubMed Web of Science ®Google Scholar
• Wang N, Liang H, Zen K. 2014. Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front Immunol. 5(614). DOI:10.3389/fimmu.2014.00614.
   Google Scholar
• Wang T, Li X-L, Liu M, Song X-J, Zhang H, Wang Y-B, Tian B-P, Xing X-S, Li S-Y. 2017. Epidemiological characteristics and environmental risk factors of severe fever with thrombocytopenia syndrome in Hubei Province, China, from 2011 to 2016. Front Microbiol. 8:387.
   PubMed Web of Science ®Google Scholar
• Win AM, Nguyen YTH, Kim Y, Ha N-Y, Kang J-G, Kim H, San B, Kyaw O, Htike WW, Choi D-O, et al. 2020. Genotypic heterogeneity of Orientia tsutsugamushi in scrub typhus patients and thrombocytopenia syndrome co-infection, Myanmar. Emerg Infect Dis. 26(8):1878–1881.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2018. 2018 Annual review of diseases prioritized under the research and development blueprint. https://www.who.int/news-room/events/detail/2018/02/06/default-calendar/2018-annual-review-of-diseases-prioritized-under-the-research-anddevelopment-blueprint.
   Google Scholar
• Xing Y, Liu J, Niu G, Ding S, Gong L, Liu J. 2015. Epidemiological investigation of predominance tick and the infectious status of severe fever thrombocytopenia syndrome virus in Penglai and Laizhou counties, Shandong province. Zhonghua Yu Fang Yi Xue Za Zhi. 49(11):993–997.
   PubMedGoogle Scholar
• Xu B, Liu L, Huang X, Ma H, Zhang Y, Du Y, Wang P, Tang X, Wang H, Kang K, et al. 2011. Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus. PLoS Pathog. 7(11):e1002369. [pubmedMismatch]
   PubMed Web of Science ®Google Scholar
• Yoo JR, Choi JH, Kim YR, Lee KH, Heo ST. 2019. Occupational risk of severe fever with thrombocytopenia syndrome in healthcare workers. Open Forum Infect Dis. 6(5):ofz210.
   PubMed Web of Science ®Google Scholar
• Yoo JR, Kim SH, Kim YR, Lee KH, Oh WS, Heo ST. 2019. Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome. Korean J Intern Med. 34(4):902–909.
   PubMed Web of Science ®Google Scholar
• Yoshikawa R, Sakabe S, Urata S, Yasuda J, Dutch RE. 2019. Species-specific pathogenicity of severe fever with thrombocytopenia syndrome virus is determined by anti-STAT2 activity of NSs. J Virol. 93(10):e02226–18.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Shimojima M, Fukushi S, Tani H, Fukuma A, Taniguchi S, Singh H, Suda Y, Shirabe K, Toda S, et al. 2015. Phylogenetic and geographic relationships of severe fever with thrombocytopenia syndrome virus in China, South Korea, and Japan. J Infect Dis. 212(6):889–898.
   PubMed Web of Science ®Google Scholar
• Yu KM, Jeong HW, Park SJ, et al. 2019. Shedding and transmission modes of severe fever with thrombocytopenia syndrome Phlebovirus in a ferret model. Open Forum Infect Dis. 6(8). DOI:10.1093/ofid/ofz309.
   Web of Science ®Google Scholar
• Yu M-A, Yu K-M, Park S-J, Kim Y-I, Robles NJ, Si Y-J, Kim E-H, Kwon H-I, Jeong HW, Song M-S, et al. 2019. Seroprevalence of severe fever with thrombocytopenia syndrome Phlebovirus in domesticated deer in South Korea. Virol Sin. 34(5):501–507.
   PubMed Web of Science ®Google Scholar
• Yu X-J, Liang M-F, Zhang S-Y, Liu Y, Li J-D, Sun Y-L, Zhang L, Zhang Q-F, Popov VL, Li C, et al. 2011. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 364(16):1523–1532.
   PubMed Web of Science ®Google Scholar
• Yuan F, Zheng A. 2017. Entry of severe fever with thrombocytopenia syndrome virus. Virol Sin. 32(1):44–50.
   PubMed Web of Science ®Google Scholar
• Yuan S, Chan JF-W, Ye Z-W, Wen L, Tsang TG-W, Cao J, Huang J, Chan CC-Y, Chik KK-H, Choi GK-Y, et al. 2019. Screening of an FDA-approved drug library with a two-tier system identifies an entry inhibitor of severe fever with thrombocytopenia syndrome virus. Viruses. 11(4):385.
   PubMed Web of Science ®Google Scholar
• Yun Y, Heo ST, Kim G, Hewson R, Kim H, Park D, Cho N-H, Oh WS, Ryu SY, Kwon KT, et al. 2015. Phylogenetic analysis of severe fever with thrombocytopenia syndrome virus in South Korea and migratory bird routes between China, South Korea, and Japan. Am J Trop Med Hyg. 93(3):468–474.
   PubMed Web of Science ®Google Scholar
• Zhan J, Wang Q, Cheng J, Hu B, Li J, Zhan F, Song Y, Guo D. 2017. Current status of severe fever with thrombocytopenia syndrome in China. Virol Sin. 32(1):51–62.
   PubMed Web of Science ®Google Scholar
• Zhang D, Sun C, Yu H, Li J, Liu W, Li Z, Bao C, Liu D, Zhang N, Zhu F, et al. 2019. Environmental risk factors and geographic distribution of severe fever with thrombocytopenia syndrome in Jiangsu Province, China. Vector Borne Zoonotic Dis. 19(10):758–766.
   PubMed Web of Science ®Google Scholar
• Zhang L, Fu Y, Wang H, Guan Y, Zhu W, Guo M, Zheng N, Wu Z. 2019. Severe fever with thrombocytopenia syndrome virus-induced macrophage differentiation is regulated by miR-146. Front Immunol. 10:1095.
   PubMed Web of Science ®Google Scholar
• Zhang L-K, Wang B, Xin Q, Shang W, Shen S, Xiao G, Deng F, Wang H, Hu Z, Wang M. 2019. Quantitative proteomic analysis reveals unfolded-protein response involved in severe fever with thrombocytopenia syndrome virus infection. J Virol. 93(10):e00308–19.
   PubMed Web of Science ®Google Scholar
• Zhang Y-Z, Zhou D-J, Qin X-C, Tian J-H, Xiong Y, Wang J-B, Chen X-P, Gao D-Y, He Y-W, Jin D, et al. 2012. The ecology, genetic diversity, and phylogeny of Huaiyangshan virus in China. J Virol. 86(5):2864–2868.
   PubMed Web of Science ®Google Scholar
• Zhang Y-Z, Zhou D-J, Xiong Y, Chen X-P, He Y-W, Sun Q, Yu B, Li J, Dai Y-A, Tian J-H, et al. 2011. Hemorrhagic fever caused by a novel tick-borne bunyavirus in Huaiyangshan, China. Zhonghua Liu Xing Bing Xue Za Zhi. 32(3):209–220.
   PubMedGoogle Scholar
• Zhong Y, Yi C. 2016. MicroRNA-720 suppresses M2 macrophage polarization by targeting GATA3. Biosci Rep. 36(4). DOI:10.1042/BSR20160105.
   Google Scholar
• Zhu L, Yin F, Moming A, Zhang J, Wang B, Gao L, Ruan J, Wu Q, Wu N, Wang H, et al. 2019. First case of laboratory-confirmed severe fever with thrombocytopenia syndrome disease revealed the risk of SFTSV infection in Xinjiang, China. Emerg Microbes Infect. 8(1):1122–1125.
   PubMed Web of Science ®Google Scholar